Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Pancreatic secretion (mmu04972)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1810009J
06Rik
KLA  ATP  ATP+KLA
 NM_023707 RIKEN cDNA 1810009J06 gene (1810009J06Rik), mRNA [NM_023707] KLA .94 1.09 1.01 .98 1.05 .99 1.19
ATP .96 .90 .96 1.04 .99 1.07 1.05
KLA/ATP 1.02 .98 1.01 1.09 1.08 1.06 1.01
2210010C
04Rik
KLA  ATP  ATP+KLA
 NM_023333 RIKEN cDNA 2210010C04 gene (2210010C04Rik), mRNA [NM_023333] KLA 1.36 1.41 1.44 1.22 1.24 1.13 1.10
ATP 1.02 .98 1.05 .96 1.01 1.02 1.06
KLA/ATP 1.35 1.18 1.33 1.15 1.02 1.06 1.09
AI747448
KLA  ATP  ATP+KLA
 NM_001033199 expressed sequence AI747448 (AI747448), mRNA [NM_001033199] KLA .98 1.03 1.03 1.03 1.07 .99 1.00
ATP .99 .97 .97 1.04 1.05 1.02 1.01
KLA/ATP .96 1.04 .99 .98 .98 1.11 .98
AK043675
KLA  ATP  ATP+KLA
 AK043675 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830019B06 product:unclassifiable, full insert sequence. [AK043675] KLA 1.07 1.05 1.00 .98 1.05 1.02 1.00
ATP .92 1.07 .99 .93 1.01 1.01 1.02
KLA/ATP .96 .93 1.08 1.00 .94 .97 1.02
AK050363
KLA  ATP  ATP+KLA
 AK050363 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730040N22 product:unclassifiable, full insert sequence. [AK050363] KLA 1.00 .98 1.02 1.02 1.02 .92 .96
ATP .98 1.03 .93 .98 .96 1.02 .99
KLA/ATP 1.03 .96 .96 .95 1.02 .93 1.04
AK078587
KLA  ATP  ATP+KLA
 AK078587 11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] KLA 1.37 1.28 1.13 1.06 1.15 1.31 1.22
ATP 1.04 1.08 1.21 1.22 1.27 1.12 1.14
KLA/ATP 1.48 1.66 1.97 1.26 1.17 1.03 1.28
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Atp1a1
KLA  ATP  ATP+KLA
 NM_144900 ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] KLA .78 .94 .68 .81 .62 .55 .75
ATP 1.02 1.05 .86 .85 1.77 2.54 1.11
KLA/ATP .83 .99 .80 .75 .91 1.15 .68
Atp1a2
KLA  ATP  ATP+KLA
 NM_178405 ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] KLA 1.03 .98 1.03 1.05 1.03 .98 1.02
ATP 1.03 .98 1.06 1.05 1.05 .93 1.07
KLA/ATP 1.04 1.05 1.02 1.02 .98 .92 1.02
Atp1a3
KLA  ATP  ATP+KLA
 AK053751 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] KLA .88 .87 .74 .80 .84 .88 .93
ATP .96 .83 .80 .88 .94 .89 1.15
KLA/ATP .89 .86 .79 .90 .93 .84 .92
Atp1a3
KLA  ATP  ATP+KLA
 NM_144921 ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] KLA .99 .87 .96 .86 .81 .61 .52
ATP 1.22 1.21 1.16 1.38 1.27 .92 1.30
KLA/ATP .96 1.10 1.17 1.42 1.11 .91 .93
Atp1b1
KLA  ATP  ATP+KLA
 NM_009721 ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] KLA .97 1.02 1.08 .98 .95 1.01 1.09
ATP 1.07 1.05 1.09 1.09 1.02 1.17 1.11
KLA/ATP .99 .99 .93 1.02 1.00 1.07 1.04
Atp1b2
KLA  ATP  ATP+KLA
 NM_013415 ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] KLA 1.18 1.09 1.11 1.12 1.16 1.12 1.15
ATP .95 .98 .99 1.26 1.06 1.10 1.07
KLA/ATP 1.15 1.16 1.09 1.19 1.27 1.13 1.02
Atp1b3
KLA  ATP  ATP+KLA
 NM_007502 ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] KLA 1.86 2.10 2.25 2.21 2.68 3.26 3.45
ATP 1.08 1.09 .93 1.13 1.55 2.14 2.38
KLA/ATP 1.95 2.10 1.84 2.34 2.20 2.96 4.69
Atp1b4
KLA  ATP  ATP+KLA
 NM_133690 ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] KLA .99 1.02 1.03 1.01 .95 .90 1.00
ATP 1.00 1.05 1.04 .98 1.07 .98 .97
KLA/ATP 1.00 1.05 1.03 1.04 .96 .97 1.01
Atp2a1
KLA  ATP  ATP+KLA
 NM_007504 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 (Atp2a1), mRNA [NM_007504] KLA 1.05 1.05 1.02 .99 1.04 1.07 1.27
ATP 1.02 1.13 .96 1.13 1.10 1.17 1.12
KLA/ATP 1.15 1.11 .90 1.12 .93 1.14 .99
Atp2a2
KLA  ATP  ATP+KLA
 NM_001110140 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 1, mRNA [NM_001110140] KLA .95 1.07 .96 .84 1.17 1.16 1.53
ATP 1.16 1.27 .80 1.14 1.10 1.23 1.35
KLA/ATP 1.14 1.10 .54 1.15 .91 1.10 1.01
Atp2a2
KLA  ATP  ATP+KLA
 NM_009722 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (Atp2a2), transcript variant 2, mRNA [NM_009722] KLA .90 .90 .99 .96 1.28 1.09 1.29
ATP 1.09 1.12 .94 1.19 1.47 1.36 .98
KLA/ATP .98 .95 .72 1.06 1.44 1.30 .88
Atp2a3
KLA  ATP  ATP+KLA
 NM_016745 ATPase, Ca++ transporting, ubiquitous (Atp2a3), mRNA [NM_016745] KLA 1.10 1.12 1.17 1.14 .99 .85 .54
ATP 1.05 1.11 1.15 1.32 1.14 1.00 .60
KLA/ATP 1.21 1.22 1.31 1.26 1.05 .88 .63
Atp2b1
KLA  ATP  ATP+KLA
 AK053569 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111D10 product:unclassifiable, full insert sequence. [AK053569] KLA 1.18 1.02 .86 .87 .88 .99 .97
ATP 1.38 1.60 8.03 2.45 1.66 1.16 .94
KLA/ATP 1.32 1.41 6.67 1.98 1.15 1.08 .96
Atp2b1
KLA  ATP  ATP+KLA
 AK161995 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720440F18 product:Plasma membrane calcium pump isoform 1b (Fragment) homolog [Canis familiaris], full insert sequence. [AK16199 KLA 1.64 1.50 1.23 1.02 .71 .75 .92
ATP 1.04 1.12 1.69 1.64 1.34 1.03 .66
KLA/ATP 1.69 1.58 2.20 1.99 1.03 .67 .57
Atp2b1
KLA  ATP  ATP+KLA
 NM_026482 ATPase, Ca++ transporting, plasma membrane 1 (Atp2b1), mRNA [NM_026482] KLA 1.91 1.76 1.64 1.21 .84 .79 1.07
ATP 1.00 1.01 1.43 2.32 2.28 1.71 1.06
KLA/ATP 1.86 1.85 2.23 2.48 1.71 1.05 1.04
Atp2b2
KLA  ATP  ATP+KLA
 NM_009723 ATPase, Ca++ transporting, plasma membrane 2 (Atp2b2), transcript variant 1, mRNA [NM_009723] KLA 1.02 .93 1.01 1.01 1.04 1.00 1.09
ATP 1.00 1.03 1.01 1.05 1.05 1.04 .90
KLA/ATP .99 .95 1.04 1.06 1.01 .99 1.00
Atp2b3
KLA  ATP  ATP+KLA
 AK032322 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430519O13 product:PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASE 3 (EC 3.6.3.8) (PMCA3) (PLASMA MEMBRANE CALCIUM PUMP ISOFORM 3) (PLASMA MEMBRANE CALCIUM ATPASE ISOF KLA 1.00 1.05 1.01 1.09 1.00 1.04 1.09
ATP 1.02 .97 1.01 1.12 .95 1.19 1.16
KLA/ATP 1.01 .95 .97 1.09 1.12 1.06 1.14
BG242006
KLA  ATP  ATP+KLA
 BG242006 gb|602354740F1 NCI_CGAP_Mam1 Mus musculus cDNA clone IMAGE:4483064 5. [BG242006] KLA 2.25 2.23 2.26 2.70 2.56 2.67 1.45
ATP .92 .87 1.11 .97 .99 .97 .72
KLA/ATP 1.91 2.04 2.51 2.08 1.99 1.15 .67
BI102035
KLA  ATP  ATP+KLA
 BI102035 gb|602887753F1 NCI_CGAP_Kid14 Mus musculus cDNA clone IMAGE:5043156 5, mRNA sequence [BI102035] KLA 1.00 .99 1.05 .97 1.03 1.04 1.06
ATP .99 .97 1.02 1.06 1.02 .98 1.02
KLA/ATP 1.05 .98 1.13 1.03 1.00 1.08 1.33
Bst1
KLA  ATP  ATP+KLA
 NM_009763 bone marrow stromal cell antigen 1 (Bst1), mRNA [NM_009763] KLA 2.26 2.15 2.90 3.73 4.89 5.96 6.57
ATP 1.05 1.06 1.31 1.52 1.57 4.31 4.76
KLA/ATP 2.29 2.31 3.10 2.98 3.09 5.35 13.91
Car2
KLA  ATP  ATP+KLA
 NM_009801 carbonic anhydrase 2 (Car2), mRNA [NM_009801] KLA 9.50 10.18 12.25 12.70 14.42 16.57 6.38
ATP .98 .97 1.35 1.55 3.60 9.36 8.47
KLA/ATP 8.20 10.30 10.62 13.18 12.35 14.45 22.78
Cck
KLA  ATP  ATP+KLA
 NM_031161 cholecystokinin (Cck), mRNA [NM_031161] KLA .96 1.11 .98 .99 .91 1.00 1.10
ATP 1.00 1.00 1.03 1.13 1.02 1.17 2.72
KLA/ATP 1.08 1.00 .91 1.06 1.04 1.07 1.38
Cckar
KLA  ATP  ATP+KLA
 NM_009827 cholecystokinin A receptor (Cckar), mRNA [NM_009827] KLA 1.00 .97 1.05 1.07 .99 1.08 1.03
ATP 1.08 1.00 1.10 1.07 .94 1.00 .98
KLA/ATP .99 .98 .99 1.04 1.00 1.04 1.02
Cd38
KLA  ATP  ATP+KLA
 NM_007646 CD38 antigen (Cd38), mRNA [NM_007646] KLA 3.61 5.39 8.63 9.62 24.42 36.25 76.13
ATP 1.00 1.05 1.36 1.70 2.26 8.41 7.84
KLA/ATP 4.45 4.89 5.01 7.93 5.74 14.08 40.05
Cel
KLA  ATP  ATP+KLA
 NM_009885 carboxyl ester lipase (Cel), mRNA [NM_009885] KLA 1.06 1.02 1.06 1.07 1.07 1.08 1.11
ATP 1.01 1.04 1.18 1.09 1.09 1.21 1.09
KLA/ATP 1.06 .97 1.24 1.16 1.19 1.21 1.10
Cftr
KLA  ATP  ATP+KLA
 NM_021050 cystic fibrosis transmembrane conductance regulator homolog (Cftr), mRNA [NM_021050] KLA 1.00 1.01 1.00 1.00 1.01 1.01 1.03
ATP 1.01 .99 .99 1.02 .99 .99 1.01
KLA/ATP 1.03 1.01 .99 .99 .98 1.02 1.01
Chrm3
KLA  ATP  ATP+KLA
 AK051841 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230008K23 product:unclassifiable, full insert sequence. [AK051841] KLA .92 .97 1.02 1.05 .96 .99 1.00
ATP 1.00 .99 .99 .95 1.05 1.02 1.01
KLA/ATP .91 .98 1.06 1.07 .94 1.00 .94
Chrm3
KLA  ATP  ATP+KLA
 NM_033269 cholinergic receptor, muscarinic 3, cardiac (Chrm3), mRNA [NM_033269] KLA .91 .99 .98 .93 1.08 1.01 1.06
ATP .97 1.05 1.03 .95 .99 1.01 1.10
KLA/ATP 1.05 1.09 .99 1.00 .98 1.03 1.00
Clca1
KLA  ATP  ATP+KLA
 NM_009899 chloride channel calcium activated 1 (Clca1), mRNA [NM_009899] KLA .97 1.01 1.02 1.02 .99 .92 1.05
ATP .98 1.03 .97 .99 1.03 .98 1.01
KLA/ATP .94 1.10 1.02 1.10 1.03 1.02 .98
Clca2
KLA  ATP  ATP+KLA
 NM_030601 chloride channel calcium activated 2 (Clca2), mRNA [NM_030601] KLA 1.01 .99 .94 1.05 1.00 1.05 .98
ATP 1.03 1.02 .98 1.01 1.03 1.03 1.03
KLA/ATP 1.00 .97 1.05 .98 1.00 1.04 1.03
Clca3
KLA  ATP  ATP+KLA
 NM_017474 chloride channel calcium activated 3 (Clca3), mRNA [NM_017474] KLA 1.15 1.22 1.24 1.20 1.21 1.21 1.18
ATP .97 1.01 1.05 1.00 1.09 .92 1.07
KLA/ATP 1.20 1.20 1.14 1.11 1.16 1.12 1.05
Clca4
KLA  ATP  ATP+KLA
 NM_139148 chloride channel calcium activated 4 (Clca4), mRNA [NM_139148] KLA 1.06 1.08 .98 1.03 1.05 1.00 1.05
ATP 1.03 .98 1.01 1.03 1.00 1.02 1.02
KLA/ATP 1.05 .98 1.01 1.05 1.02 1.00 1.04
Clca5
KLA  ATP  ATP+KLA
 NM_178697 chloride channel calcium activated 5 (Clca5), mRNA [NM_178697] KLA .95 .94 1.03 .98 1.07 1.01 .98
ATP .96 1.03 1.00 .96 .92 1.09 1.04
KLA/ATP .89 .95 1.06 1.04 .98 .92 1.01
Clca6
KLA  ATP  ATP+KLA
 NM_207208 chloride channel calcium activated 6 (Clca6), mRNA [NM_207208] KLA .95 1.05 1.02 1.00 1.01 .98 .99
ATP 1.07 1.11 1.07 1.02 1.03 1.08 1.00
KLA/ATP 1.07 .95 1.07 1.04 .96 1.02 .99
Cpa1
KLA  ATP  ATP+KLA
 NM_025350 carboxypeptidase A1 (Cpa1), mRNA [NM_025350] KLA 1.09 1.08 .95 1.04 .99 .98 1.02
ATP .95 1.04 1.02 .93 .98 .99 1.06
KLA/ATP .93 1.00 1.01 .91 .99 .99 1.07
Cpa2
KLA  ATP  ATP+KLA
 NM_001024698 carboxypeptidase A2, pancreatic (Cpa2), mRNA [NM_001024698] KLA .90 .92 .91 .88 .84 .91 1.13
ATP 1.00 .96 .92 .94 .87 .92 .98
KLA/ATP .94 .90 .84 .83 .92 .82 1.01
Cpa3
KLA  ATP  ATP+KLA
 NM_007753 carboxypeptidase A3, mast cell (Cpa3), mRNA [NM_007753] KLA 1.03 1.11 1.20 1.04 1.10 1.05 1.00
ATP .99 .98 .99 .93 .94 1.02 .93
KLA/ATP 1.02 1.11 1.08 1.03 .96 1.02 .93
Cpb1
KLA  ATP  ATP+KLA
 NM_029706 carboxypeptidase B1 (tissue) (Cpb1), mRNA [NM_029706] KLA 1.01 1.07 1.10 1.08 1.05 1.17 1.00
ATP .94 .95 1.02 .98 .95 1.05 1.00
KLA/ATP 1.02 1.02 1.09 1.04 1.12 1.07 1.26
Cpb2
KLA  ATP  ATP+KLA
 AK015095 adult male testis cDNA, RIKEN full-length enriched library, clone:4930405E17 product:unclassifiable, full insert sequence. [AK015095] KLA 1.00 .93 .99 1.01 .99 1.00 .95
ATP .96 1.02 .98 .95 1.01 .98 1.01
KLA/ATP .96 .99 .92 .97 .98 1.04 1.00
Cpb2
KLA  ATP  ATP+KLA
 NM_019775 carboxypeptidase B2 (plasma) (Cpb2), mRNA [NM_019775] KLA 1.13 1.19 .95 1.16 1.03 1.01 .84
ATP .98 1.23 .91 1.00 .88 1.06 1.07
KLA/ATP 1.08 1.25 1.10 1.12 1.15 1.07 1.12
Ctrb1
KLA  ATP  ATP+KLA
 NM_025583 chymotrypsinogen B1 (Ctrb1), mRNA [NM_025583] KLA 1.52 1.57 1.59 1.66 1.67 1.79 1.23
ATP .91 .95 1.22 1.28 1.30 1.54 1.18
KLA/ATP 1.51 1.60 1.92 1.72 1.65 1.54 1.47
Ctrl
KLA  ATP  ATP+KLA
 NM_023182 chymotrypsin-like (Ctrl), mRNA [NM_023182] KLA 1.82 1.98 2.08 1.93 2.02 2.01 1.53
ATP 1.09 1.17 1.29 1.39 1.69 1.97 1.26
KLA/ATP 2.43 2.69 4.20 5.20 4.65 3.05 2.28
Ela3
KLA  ATP  ATP+KLA
 NM_026419 elastase 3, pancreatic (Ela3), mRNA [NM_026419] KLA 1.02 1.02 1.05 1.08 1.11 1.10 1.13
ATP .95 .99 1.04 .96 .98 1.03 .98
KLA/ATP 1.03 1.05 1.13 1.03 1.03 .93 .98
Fxyd2
KLA  ATP  ATP+KLA
 NM_052823 FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] KLA 1.07 .97 1.09 .98 1.02 .96 .83
ATP 1.07 1.22 1.00 1.14 1.00 1.22 4.11
KLA/ATP 1.06 1.11 .96 1.13 .98 1.01 1.02
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Itpr1
KLA  ATP  ATP+KLA
 NM_010585 inositol 1,4,5-triphosphate receptor 1 (Itpr1), mRNA [NM_010585] KLA 3.66 3.69 6.74 8.11 7.08 4.40 1.22
ATP 1.08 .95 1.19 .94 1.09 1.00 .68
KLA/ATP 3.48 3.58 5.86 6.03 4.01 2.31 .97
Itpr2
KLA  ATP  ATP+KLA
 NM_019923 inositol 1,4,5-triphosphate receptor 2 (Itpr2), transcript variant 1, mRNA [NM_019923] KLA 1.41 1.38 1.43 1.42 1.30 1.07 1.01
ATP 1.00 1.00 .97 .97 1.07 1.15 1.06
KLA/ATP 1.39 1.48 1.64 1.42 1.07 .83 .95
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Kcnma1
KLA  ATP  ATP+KLA
 NM_010610 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (Kcnma1), mRNA [NM_010610] KLA 1.04 1.08 .96 .98 1.01 1.08 .96
ATP 1.03 .96 .99 .97 .98 .95 .99
KLA/ATP .99 1.07 1.04 1.04 .99 .95 .93
Kcnq1
KLA  ATP  ATP+KLA
 NM_008434 potassium voltage-gated channel, subfamily Q, member 1 (Kcnq1), mRNA [NM_008434] KLA .80 .77 .67 .78 .65 .54 .42
ATP 1.06 .94 1.00 1.12 .97 .69 .60
KLA/ATP .75 .85 .83 .87 .70 .62 .56
Mm.10223
5
KLA  ATP  ATP+KLA
 146149208 Unknown KLA .82 .77 .73 .90 .97 1.03 1.10
ATP 1.04 1.05 .94 .88 1.01 .98 1.31
KLA/ATP .80 .78 .83 .84 .83 .95 1.16
Mm.24987
3
KLA  ATP  ATP+KLA
 161621251 Unknown KLA 1.11 1.02 1.08 1.36 1.47 1.64 3.59
ATP 1.05 1.00 1.00 .96 1.04 1.20 1.13
KLA/ATP 1.08 1.12 1.23 1.06 1.09 1.31 1.81
Mm.26885
5
KLA  ATP  ATP+KLA
 142350483 Unknown KLA .85 .82 1.01 .90 .88 1.00 1.06
ATP 1.00 .99 .91 .91 .93 .88 .93
KLA/ATP .90 .96 .92 .87 .85 .86 1.01
Mm.34692
KLA  ATP  ATP+KLA
 56550070 Unknown KLA 1.05 1.01 1.01 1.02 1.02 1.00 1.02
ATP .97 1.05 1.03 1.01 1.00 .98 .95
KLA/ATP .92 1.03 1.05 1.01 .98 1.00 1.03
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44004
0
KLA  ATP  ATP+KLA
 141802748 Unknown KLA 1.02 1.09 1.00 1.03 .97 1.09 .97
ATP .95 1.02 .94 .95 1.05 .98 1.08
KLA/ATP 1.09 .99 1.09 .94 1.04 .99 1.06
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Mm.71913
KLA  ATP  ATP+KLA
 118130231 Unknown KLA .93 1.00 1.06 .97 .95 .98 1.04
ATP 1.00 .98 1.08 1.02 .92 .90 .99
KLA/ATP .99 1.01 1.00 .99 .99 .99 1.01
Pla2g10
KLA  ATP  ATP+KLA
 NM_011987 phospholipase A2, group X (Pla2g10), mRNA [NM_011987] KLA .99 1.11 1.02 .99 1.00 1.01 1.02
ATP 1.02 .97 1.01 1.03 1.00 1.02 1.04
KLA/ATP 1.04 .96 .95 1.04 1.06 1.05 1.01
Pla2g12a
KLA  ATP  ATP+KLA
 NM_023196 phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] KLA 1.03 1.06 .97 1.00 .78 .75 .92
ATP .91 .99 1.29 1.30 1.20 1.48 1.71
KLA/ATP .92 .99 1.19 1.16 1.06 1.12 1.36
Pla2g12a
KLA  ATP  ATP+KLA
 NM_183423 phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] KLA .90 1.00 .87 .95 .76 .68 .88
ATP .96 .94 1.26 1.24 1.19 1.47 1.88
KLA/ATP .89 .90 1.08 1.07 1.06 1.02 1.59
Pla2g12b
KLA  ATP  ATP+KLA
 NM_023530 phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] KLA .98 .95 1.05 .99 1.03 .99 .94
ATP 1.02 1.04 1.07 1.05 .92 1.04 1.00
KLA/ATP .98 .92 1.10 1.11 1.09 1.03 1.04
Pla2g1b
KLA  ATP  ATP+KLA
 NM_011107 phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] KLA 1.00 1.01 1.01 1.11 1.00 1.28 1.00
ATP .98 1.03 1.09 1.03 1.01 1.02 1.04
KLA/ATP .93 .94 1.01 1.00 .94 1.09 1.07
Pla2g2a
KLA  ATP  ATP+KLA
 NM_001082531 phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] KLA 1.08 .99 1.00 1.06 .98 1.01 .94
ATP 1.07 .98 1.04 1.06 .90 .98 .98
KLA/ATP .98 1.03 1.00 1.04 .94 .97 .96
Pla2g2c
KLA  ATP  ATP+KLA
 NM_008868 phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] KLA .98 .99 1.05 .98 1.01 1.00 1.04
ATP 1.08 1.06 1.09 .93 .92 .92 1.00
KLA/ATP 1.03 1.04 1.02 1.04 .98 1.01 1.02
Pla2g2d
KLA  ATP  ATP+KLA
 NM_011109 phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] KLA 1.02 1.02 .99 .99 1.00 1.01 1.00
ATP .95 1.11 1.10 1.11 .98 .99 1.12
KLA/ATP 1.02 1.00 1.19 1.11 1.00 .96 1.01
Pla2g2e
KLA  ATP  ATP+KLA
 NM_012044 phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] KLA .78 .75 .74 .72 .62 .69 1.40
ATP 1.06 1.00 .92 1.04 .83 .76 3.74
KLA/ATP .78 .80 .69 .74 .70 .74 2.24
Pla2g2f
KLA  ATP  ATP+KLA
 NM_012045 phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] KLA 1.02 .99 1.03 1.01 1.00 .95 .99
ATP 1.01 1.06 1.11 .97 1.09 1.11 .99
KLA/ATP 1.10 1.05 1.04 .95 1.04 1.01 .96
Pla2g3
KLA  ATP  ATP+KLA
 NM_172791 phospholipase A2, group III (Pla2g3), mRNA [NM_172791] KLA 1.04 1.05 1.02 1.01 1.04 1.11 1.00
ATP .96 .97 1.10 .91 .99 .97 1.08
KLA/ATP 1.03 1.11 1.10 .98 .95 .98 1.07
Pla2g5
KLA  ATP  ATP+KLA
 NM_011110 phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] KLA .65 .62 .56 .53 .62 1.60 3.01
ATP .90 .82 .88 1.69 1.82 1.26 6.32
KLA/ATP .63 .59 .65 .63 .91 1.56 5.59
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Pnlip
KLA  ATP  ATP+KLA
 AK007357 10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357] KLA .95 1.03 1.02 1.02 1.04 1.06 1.10
ATP 1.05 1.00 .95 1.10 1.00 1.03 1.02
KLA/ATP 1.02 1.00 .89 1.09 1.09 1.06 1.06
Pnlip
KLA  ATP  ATP+KLA
 NM_026925 pancreatic lipase (Pnlip), mRNA [NM_026925] KLA 1.04 .97 1.04 1.00 1.02 .99 .97
ATP 1.04 1.04 1.04 .96 .95 1.02 .97
KLA/ATP .99 .95 .97 .99 .96 .93 1.00
Pnliprp1
KLA  ATP  ATP+KLA
 NM_018874 pancreatic lipase related protein 1 (Pnliprp1), mRNA [NM_018874] KLA .99 .95 .96 .99 .94 .96 1.01
ATP 1.00 1.00 .98 .96 .99 .87 1.09
KLA/ATP 1.01 1.06 1.01 1.02 1.03 .96 .92
Pnliprp2
KLA  ATP  ATP+KLA
 NM_011128 pancreatic lipase-related protein 2 (Pnliprp2), mRNA [NM_011128] KLA 1.01 .97 1.02 1.07 1.08 .98 1.00
ATP 1.05 1.08 .98 1.02 1.00 1.00 1.02
KLA/ATP 1.05 1.04 .96 .99 1.01 1.03 1.05
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prss2
KLA  ATP  ATP+KLA
 NM_009430 protease, serine, 2 (Prss2), mRNA [NM_009430] KLA .94 .99 .95 1.03 .89 1.08 1.06
ATP 1.04 .95 1.00 1.03 .96 .97 1.00
KLA/ATP 1.05 .96 1.01 1.05 1.00 1.11 1.11
RP23-395
H4.4
KLA  ATP  ATP+KLA
 NM_007919 elastase 2A (Ela2a), mRNA [NM_007919] KLA 1.02 1.00 1.01 .99 1.04 .99 .99
ATP 1.03 1.01 .97 .90 1.06 .99 1.00
KLA/ATP 1.00 1.06 1.01 .97 .99 1.00 .99
Rab11a
KLA  ATP  ATP+KLA
 NM_017382 RAB11a, member RAS oncogene family (Rab11a), mRNA [NM_017382] KLA .96 .92 .94 .94 1.01 1.05 1.00
ATP 1.04 1.08 1.09 1.15 .88 .73 .87
KLA/ATP .99 .98 .96 1.03 .84 .74 .97
Rab27b
KLA  ATP  ATP+KLA
 NM_030554 RAB27b, member RAS oncogene family (Rab27b), transcript variant 1, mRNA [NM_030554] KLA 1.06 1.04 .99 1.00 1.01 .97 1.02
ATP 1.00 .94 .99 1.07 1.01 1.02 .98
KLA/ATP .97 1.04 .97 1.03 1.03 1.02 .99
Rab3d
KLA  ATP  ATP+KLA
 NM_031874 RAB3D, member RAS oncogene family (Rab3d), mRNA [NM_031874] KLA .83 .83 .86 .92 .82 .67 .72
ATP 1.07 1.08 1.03 1.19 .83 .54 .88
KLA/ATP .87 .86 .80 .93 .71 .62 .67
Rab8a
KLA  ATP  ATP+KLA
 NM_023126 RAB8A, member RAS oncogene family (Rab8a), mRNA [NM_023126] KLA 1.41 1.41 1.45 1.52 1.77 1.71 1.53
ATP 1.08 1.19 .96 1.31 .98 1.21 1.58
KLA/ATP 1.56 1.62 1.43 2.06 1.34 1.34 2.42
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Rap1a
KLA  ATP  ATP+KLA
 AK030897 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830450G12 product:RAS-related protein-1a, full insert sequence [AK030897] KLA .83 .80 .92 1.04 1.06 .91 1.06
ATP 1.04 .92 1.11 1.03 1.05 .73 .72
KLA/ATP .83 .81 .97 .75 1.14 .71 .53
Rap1a
KLA  ATP  ATP+KLA
 NM_145541 RAS-related protein-1a (Rap1a), mRNA [NM_145541] KLA .87 .78 .76 .86 .86 .84 1.01
ATP .91 .95 1.33 1.20 1.27 1.04 .81
KLA/ATP .68 .75 .92 .85 1.13 .90 .74
Rap1b
KLA  ATP  ATP+KLA
 M79314 GTP-binding protein RAP1b mRNA, partial cds. [M79314] KLA 2.61 2.95 2.81 2.76 3.07 2.67 1.88
ATP 1.00 1.10 1.00 1.94 1.94 1.72 1.31
KLA/ATP 2.49 2.45 2.03 4.23 3.03 2.60 1.86
Rap1b
KLA  ATP  ATP+KLA
 NM_024457 RAS related protein 1b (Rap1b), mRNA [NM_024457] KLA 2.21 2.35 2.71 2.51 2.86 2.44 1.54
ATP 1.05 .92 .93 1.14 1.30 1.26 1.07
KLA/ATP 2.23 2.15 1.57 2.53 2.16 1.67 1.38
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Ryr2
KLA  ATP  ATP+KLA
 BC043140 ryanodine receptor 2, cardiac, mRNA (cDNA clone IMAGE:6822493), complete cds. [BC043140] KLA .97 1.03 1.01 1.03 1.03 1.01 1.05
ATP .99 .98 1.03 1.02 1.01 1.09 1.04
KLA/ATP .98 1.00 .98 1.04 1.04 1.06 1.00
Ryr2
KLA  ATP  ATP+KLA
 NM_023868 ryanodine receptor 2, cardiac (Ryr2), mRNA [NM_023868] KLA 1.04 1.02 1.00 1.00 1.03 .97 .96
ATP .95 1.04 1.00 .94 .98 1.01 1.08
KLA/ATP .99 .97 1.02 1.03 1.00 .98 1.00
Sct
KLA  ATP  ATP+KLA
 NM_011328 secretin (Sct), mRNA [NM_011328] KLA 1.26 1.40 1.46 1.57 1.67 1.67 1.39
ATP .94 .96 1.00 1.03 1.03 1.00 1.11
KLA/ATP 1.31 1.41 1.24 1.22 1.18 1.20 1.23
Sctr
KLA  ATP  ATP+KLA
 NM_001012322 secretin receptor (Sctr), mRNA [NM_001012322] KLA .96 .94 1.01 1.01 1.02 .94 .99
ATP 1.06 .97 .99 .95 1.02 .99 .98
KLA/ATP 1.03 1.07 .99 1.07 .94 .99 1.00
Slc12a2
KLA  ATP  ATP+KLA
 NM_009194 solute carrier family 12, member 2 (Slc12a2), mRNA [NM_009194] KLA 1.17 1.01 1.01 1.02 .79 .76 .79
ATP 1.09 1.09 1.16 1.56 1.42 1.40 .78
KLA/ATP 1.07 1.19 1.40 1.55 1.18 1.11 .85
Slc26a3
KLA  ATP  ATP+KLA
 AK035716 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530095G06 product:solute carrier family 26, member 3, full insert sequence. [AK035716] KLA .99 1.00 .99 1.02 .92 1.01 .99
ATP 1.04 1.05 .96 .99 .97 .98 1.28
KLA/ATP .97 1.07 .96 .99 .94 1.04 1.05
Slc26a3
KLA  ATP  ATP+KLA
 NM_021353 solute carrier family 26, member 3 (Slc26a3), mRNA [NM_021353] KLA 1.01 .98 1.00 1.02 .96 1.00 .96
ATP .99 .98 .96 .99 .99 1.01 .96
KLA/ATP 1.04 .99 1.04 .96 .98 .97 1.02
Slc4a2
KLA  ATP  ATP+KLA
 NM_009207 solute carrier family 4 (anion exchanger), member 2 (Slc4a2), mRNA [NM_009207] KLA .96 .89 1.01 .78 .99 .85 .89
ATP 1.26 1.27 .48 .61 .70 .78 1.49
KLA/ATP 1.18 1.11 .49 .63 .67 .69 1.52
Slc4a4
KLA  ATP  ATP+KLA
 NM_018760 solute carrier family 4 (anion exchanger), member 4 (Slc4a4), mRNA [NM_018760] KLA 1.02 1.03 1.01 1.02 .98 1.01 1.01
ATP 1.03 .97 .94 1.00 1.02 1.00 1.02
KLA/ATP 1.02 1.04 .85 1.03 .98 .97 1.00
Slc9a1
KLA  ATP  ATP+KLA
 NM_016981 solute carrier family 9 (sodium/hydrogen exchanger), member 1 (Slc9a1), mRNA [NM_016981] KLA 1.74 1.72 1.95 1.84 1.86 1.53 1.49
ATP 1.11 1.28 .95 1.46 1.98 2.67 1.47
KLA/ATP 1.85 2.02 1.70 2.47 2.18 3.18 3.48
Slc9a1
KLA  ATP  ATP+KLA
 U51112 Na+/H+ exchanger (NHE-1) mRNA, complete cds. [U51112] KLA 1.78 1.83 2.11 1.90 1.91 1.61 1.40
ATP 1.07 1.14 .98 1.54 2.00 2.85 1.44
KLA/ATP 1.97 2.16 2.01 2.44 2.30 3.37 3.15
Tpcn2
KLA  ATP  ATP+KLA
 NM_146206 two pore segment channel 2 (Tpcn2), mRNA [NM_146206] KLA .37 .38 .44 .51 .78 .94 .96
ATP 1.08 1.05 .75 .70 1.12 .87 1.24
KLA/ATP .43 .41 .32 .39 .58 .83 1.34
Trpc1
KLA  ATP  ATP+KLA
 AK038676 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230054C16 product:transient receptor potential cation channel, subfamily C, member 1, full insert sequence. [AK038676] KLA .99 .96 1.07 1.00 1.03 .97 .95
ATP .99 1.01 1.03 1.01 1.01 1.04 .94
KLA/ATP .94 1.02 .95 .96 .97 .95 1.00
Trpc1
KLA  ATP  ATP+KLA
 NM_011643 transient receptor potential cation channel, subfamily C, member 1 (Trpc1), mRNA [NM_011643] KLA 1.06 1.05 .97 1.08 1.06 1.00 1.06
ATP 1.04 .93 .99 .97 .91 1.00 .94
KLA/ATP 1.04 1.04 .86 1.01 .97 .95 .96